[Form 3] Nano-X Imaging Ltd. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Nano-X Imaging Ltd. director Kainan Noga filed an initial ownership report showing a mix of ordinary shares, restricted share units and stock options in the company. One block of ordinary shares consists of restricted share units granted on December 10, 2025 that vest in twelve equal monthly installments over one year.
Noga also holds stock options over 12,505, 50,000 and 10,000 ordinary shares with exercise prices of $64.6100, $17.6300 and $11.5200, expiring in 2031, 2032 and 2033, respectively. Some ordinary shares are held indirectly through I.B.L. Business Consulting Ltd., which is wholly owned by Noga.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Kainan Noga
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 12,505 shares (Direct);
Ordinary shares — 7,792 shares (Direct);
Ordinary shares — 794 shares (Indirect, By: I.B.L. Business Consulting Ltd, a company wholly owned by the reporting person.)
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on December 10, 2025 and that vest in twelve equal monthly installments such that they will be fully vested upon the one-year anniversary of the grant date. The options reported in this row were granted to the Reporting Person by the Issuer on February 9, 2021 and are fully vested and exercisable as of the date of this report. The options reported in this row were granted to the Reporting Person by the Issuer on December 28, 2022 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., May 16, 2022), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (May 16, 2026). The options reported in this row were granted to the Reporting Person by the Issuer on December 31, 2023 and vest and become exercisable in 16 equal installments of 6.25% each on each three-month anniversary of the date of approval of the grant by the Issuer's Board of Directors (i.e., August 14, 2023), such that all options reported in this row will be exercisable on the four-year anniversary of that grant approval date (August 14, 2027).
Nano-X Imaging Ltd.